← Browse by Condition
Medical Condition
percutaneous coronary intervention
Total Trials
8
Recruiting Now
8
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for percutaneous coronary intervention sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — percutaneous coronary intervention Clinical Trials
How many clinical trials are currently recruiting for percutaneous coronary intervention?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for percutaneous coronary intervention, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for percutaneous coronary intervention?
percutaneous coronary intervention research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a percutaneous coronary intervention clinical trial?
Eligibility criteria for percutaneous coronary intervention trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
2 trials
2 trials
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07846462
Recruiting
Enrollment
2,640 pts
Location
China
Sponsor
Jilin University
NCT07446023
Recruiting
Enrollment
292 pts
Location
China
Sponsor
China National Center for Card...
NCT05669222
Recruiting
Enrollment
5,000 pts
Location
China
Sponsor
China National Center for Card...
NCT05230446
Recruiting
Enrollment
609 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
NCT07330622
Recruiting
Enrollment
1,000 pts
Location
Poland
Sponsor
National Institute of Cardiolo...
NCT02762162
Recruiting
Enrollment
5,000 pts
Location
France
Sponsor
Action, France
NCT07872098
Recruiting
Enrollment
36 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
NCT06878729
Recruiting
Enrollment
74 pts
Location
Poland
Sponsor
National Institute of Cardiolo...
Related Conditions
coronary artery disease (3) coronary occlusion (2) acute coronary syndromes (1) chronic coronary syndrome (1) intravenous ultrasound (1) coronary physiology (1) st segment elevation myocardial infarction (1) multivessel coronary artery disease (1) multi vessel coronary artery disease (1) non st elevation myocardial infarction (1) unstable angina (1) stable angina (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology